Aclaris Therapeutics Inc (ACRS)

12:05 PM

Will Aclaris Therapeutics Inc. stock benefit from green energy trendsTrade Exit Report & Real-Time Volume Surge Alerts - ulpravda.ru

12:05 PM

10:32 AM

Why analysts upgrade Aclaris Therapeutics Inc. stockMarket Sentiment Summary & Reliable Momentum Entry Alerts - ulpravda.ru

10:32 AM

08:28 AM

Aclaris joins Nasdaq biotech index, marking milestone for clinical-stage firm - MSN

08:28 AM

12:00 PM

Early Trial Data Puts Aclaris’ ATI-052 on Fast Track Toward Bigger Bets - MyChesCo

12:00 PM

Jan 07, 2026

Why Aclaris Therapeutics Inc. stock could rally in 2025Long-Term Growth Stocks & Superior Growth Trading - ulpravda.ru

Jan 07, 2026

Jan 06, 2026

Jefferies reiterates Buy rating on Aclaris Therapeutics stock at $7 price target - Investing.com Canada

Jan 06, 2026

Jan 06, 2026

Aclaris Therapeutics Reports Positive Interim Phase 1a ATI-052 Data, Speeds Up Development Plans - MarketBeat

Jan 06, 2026

Jan 06, 2026

Aclaris Therapeutics Reports Positive Phase 1a Data For ATI-052 - Nasdaq

Jan 06, 2026

Jan 06, 2026

Aclaris advances ATI-052 after positive Phase 1a results - TipRanks

Jan 06, 2026

Jan 06, 2026

Aclaris Therapeutics Announces Positive Interim Results from Phase 1a Trial of ATI-052 - TradingView — Track All Markets

Jan 06, 2026

Jan 06, 2026

Aclaris reports positive results for anti-inflammatory drug ATI-052 By Investing.com - Investing.com Australia

Jan 06, 2026

Jan 06, 2026

ACRS: ATI-052 showed best-in-class potential in phase 1a, enabling rapid advancement to phase 1b trials - TradingView — Track All Markets

Jan 06, 2026

Jan 06, 2026

Aclaris Therapeutics Reports Positive Interim Results for ATI-052 Phase 1a Trials and Outlines Future Development Plans - Quiver Quantitative

Jan 06, 2026

Jan 06, 2026

New Aclaris antibody shows potential for 3‑month dosing in skin and asthma care - Stock Titan

Jan 06, 2026

Jan 05, 2026

What analysts say about Aclaris Therapeutics Inc 8AT stockStock Market Trends & Affordable Portfolio Trading - earlytimes.in

Jan 05, 2026

Jan 05, 2026

Hair Loss Treatment Market Booming with Rapid Growth Through 2032 | Viviscal, Cipla Inc., Aclaris Therapeutics, Inc. - openPR.com

Jan 05, 2026

Jan 03, 2026

Three Bridge Wealth Advisors LLC Takes Position in Aclaris Therapeutics, Inc. $ACRS - MarketBeat

Jan 03, 2026

Jan 01, 2026

Why Aclaris Therapeutics Inc. stock remains undervaluedMoving Average Strategies & Exceptional Profit Trading - bollywoodhelpline.com

Jan 01, 2026

Dec 29, 2025

Aclaris Therapeutics Joins Russell 3000 and Russell 2000 Indexes - MSN

Dec 29, 2025

Dec 29, 2025

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Dec 29, 2025

Dec 29, 2025

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Dec 29, 2025

Dec 28, 2025

What drives Aclaris Therapeutics Inc stock priceEarnings Forecast Updates & Big Profit Low Trading - earlytimes.in

Dec 28, 2025

Dec 24, 2025

Aclaris Joins Nasdaq Biotech Index, Marking Milestone for Clinical-Stage Firm - MyChesCo

Dec 24, 2025

Dec 22, 2025

Aclaris Therapeutics, Inc.(NasdaqGS: ACRS) added to NASDAQ Biotechnology Index - marketscreener.com

Dec 22, 2025

Dec 21, 2025

Gains Report: Is Aclaris Therapeutics Inc stock a good choice for value investorsJuly 2025 Opening Moves & AI Forecast for Swing Trade Picks - moha.gov.vn

Dec 21, 2025

Dec 21, 2025

Dow Update: What valuation multiples suggest for Aclaris Therapeutics Inc. stockWeekly Trade Review & Accurate Buy Signal Notifications - Улправда

Dec 21, 2025

Dec 20, 2025

Is Aclaris Therapeutics Inc. (8AT) stock good for wealth creationWeekly Trade Recap & Low Drawdown Momentum Trade Ideas - Улправда

Dec 20, 2025

Dec 20, 2025

Will Aclaris Therapeutics Inc. stock deliver strong dividend growthJuly 2025 Breakouts & Risk Managed Investment Strategies - Улправда

Dec 20, 2025

Dec 20, 2025

Why Aclaris Therapeutics Inc. stock could see breakout soonJuly 2025 Sector Moves & Safe Capital Growth Tips - Улправда

Dec 20, 2025

Dec 20, 2025

Why Aclaris Therapeutics Inc. stock is rated strong buyJuly 2025 Gainers & Free Community Consensus Stock Picks - Улправда

Dec 20, 2025

Dec 20, 2025

How analysts rate Aclaris Therapeutics Inc. stock todayJuly 2025 Catalysts & Safe Capital Preservation Plans - Улправда

Dec 20, 2025

Dec 20, 2025

Layoff Watch: Why Aclaris Therapeutics Inc. stock could rally in 2025 - Улправда

Dec 20, 2025

Dec 20, 2025

Aclaris Therapeutics Begins Phase 1a/1b Trial for Investigational Bispecific Antibody ATI-052 - MSN

Dec 20, 2025

Dec 19, 2025

Aclaris Therapeutics Added to the NASDAQ Biotechnology Index - Investing News Network

Dec 19, 2025

Dec 19, 2025

Aclaris Therapeutics Included in Nasdaq Biotechnology Index - marketscreener.com

Dec 19, 2025

Dec 19, 2025

Aclaris Therapeutics Added to Nasdaq Biotechnology Index Effective December 19, 2025 - Quiver Quantitative

Dec 19, 2025

Dec 19, 2025

Aclaris Therapeutics Added to the NASDAQ Biotechnology Index (NBI) - The Manila Times

Dec 19, 2025

Dec 19, 2025

Is Aclaris Therapeutics Inc. stock safe for conservative investorsJuly 2025 Weekly Recap & Weekly Top Stock Performers List - Улправда

Dec 19, 2025

Dec 19, 2025

Aclaris Therapeutics, Inc.'s (NASDAQ:ACRS) 25% Share Price Surge Not Quite Adding Up - simplywall.st

Dec 19, 2025

Dec 18, 2025

Rally Mode: Is Aclaris Therapeutics Inc. (8AT) stock good for wealth creationTrade Risk Assessment & AI Forecasted Entry/Exit Points - Улправда

Dec 18, 2025

Dec 18, 2025

Aclaris Therapeutics Earnings Notes - Trefis

Dec 18, 2025

Dec 17, 2025

Can Upcoming ATI-2138 And Bosakitug Data Drive Momentum For Aclaris Therapeutics In 2026? - RTTNews

Dec 17, 2025

Dec 08, 2025

Aclaris Therapeutics Stock Jump Looks Great, But How Secure Is That Gain? - Trefis

Dec 08, 2025

Dec 08, 2025

It is Poised to be a Bull Market for Aclaris Therapeutics Inc (ACRS) - setenews.com

Dec 08, 2025